{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:30:02Z","timestamp":1783031402630,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Basic Science Research Program"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2018R1D1A1B07047572"],"award-info":[{"award-number":["2018R1D1A1B07047572"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Research Institute"},{"name":"Jeonbuk National University Hospital"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejmech.2020.112099","type":"journal-article","created":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T02:21:22Z","timestamp":1579918882000},"page":"112099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Novel multifunctional 18F-labelled PET tracer with prostate-specific membrane antigen-targeting and hypoxia-sensitive moieties"],"prefix":"10.1016","volume":"189","author":[{"given":"Young-Do","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Thanh","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-7049","authenticated-orcid":false,"given":"Hee-Kwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112099_bib1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.emboj.7600969","article-title":"Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer","volume":"25","author":"Mesters","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2020.112099_bib2","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T","article-title":"Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen","volume":"83","author":"Murphy","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2020.112099_bib3","first-page":"6357","article-title":"Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer","volume":"9","author":"Ross","year":"2003","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112099_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.21241","article-title":"High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer","volume":"71","author":"Minner","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2020.112099_bib5","first-page":"7","article-title":"Cancer statistics, 2019, Ca-cancer","volume":"69","author":"Siegel","year":"2019","journal-title":"J.\u00a0Clin."},{"key":"10.1016\/j.ejmech.2020.112099_bib6","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1535-7163.MCT-14-0422","article-title":"Development of targeted near-infrared imaging agents for prostate cancer","volume":"13","author":"Wang","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112099_bib7","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2967\/jnumed.109.066589","article-title":"Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane Antigen\u2212Targeted imaging agent for prostate cancer","volume":"50","author":"Lapi","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112099_bib8","first-page":"6783","article-title":"In\u00a0vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two \u03b3-linked glutamate residues at the COOH terminus","volume":"61","author":"Warren","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112099_bib9","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bc3003919","article-title":"Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen","volume":"23","author":"Chen","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1039\/C6CC09781B","article-title":"PSMA-targeted contrast agents for intraoperative imaging of prostate cancer","volume":"53","author":"Bao","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112099_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2191-219X-2-23","article-title":"A\u00a0dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer","volume":"2","author":"Sch\u00e4fer","year":"2012","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ejmech.2020.112099_bib12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-Targeting and pharmacokinetic properties of DOTA-conjugated PSMA inhibitors","volume":"59","author":"Bene\u0161ov\u00e1","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib13","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/jm801055h","article-title":"Radiohalogenated prostate-specific membrane antigen (PSMA)-Based ureas as imaging agents for prostate cancer","volume":"51","author":"Chen","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm800994j","article-title":"A\u00a0series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer","volume":"52","author":"Maresca","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11934-002-0068-6","article-title":"Tumor hypoxia and the progression of prostate cancer","volume":"3","author":"Anastasiadis","year":"2002","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.ejmech.2020.112099_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"H\u00f6ckel","year":"2001","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2020.112099_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0090-4295(98)00500-7","article-title":"Hypoxic regions exist in human prostate carcinoma","volume":"53","author":"Movsas","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.ejmech.2020.112099_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000421-200110000-00009","article-title":"Hypoxia in human prostate carcinoma: an Eppendorf PO2 study","volume":"24","author":"Movsas","year":"2001","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2020.112099_bib19","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1158\/0008-5472.CAN-07-0561","article-title":"Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response","volume":"67","author":"Milosevic","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2020.112099_bib20","doi-asserted-by":"crossref","first-page":"20130676","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumors-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejmech.2020.112099_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/187152008785914798","article-title":"Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression","volume":"8","author":"Cosse","year":"2008","journal-title":"Anti Canc. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2020.112099_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01081524","article-title":"Nitroimidazoles and imaging hypoxia","volume":"22","author":"Nunn","year":"1995","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112099_bib24","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.bmcl.2013.05.015","article-title":"Synthesis and biological evaluation of a novel 99mTc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia","volume":"23","author":"Joyard","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112099_bib25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1349-7006.2009.01195.x","article-title":"Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia","volume":"100","author":"Kizaka-Kondoh","year":"2009","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejmech.2020.112099_bib26","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/STROKEAHA.107.485938","article-title":"Applications of nitroimidazole in\u00a0vivo hypoxia imaging in ischemic stroke","volume":"39","author":"Takasawa","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2020.112099_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1248\/cpb.60.402","article-title":"Development of a hypoxia-selective near-infrared fluorescent probe for non-invasive tumor imaging","volume":"60","author":"Youssif","year":"2012","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2020.112099_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.110.075663","article-title":"Molecular imaging of hypoxia","volume":"52","author":"Chitneni","year":"2011","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112099_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1998.5163","article-title":"Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma","volume":"71","author":"Varia","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejmech.2020.112099_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0360-3016(89)90146-6","article-title":"Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia","volume":"17","author":"Rasey","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2020.112099_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.apradiso.2004.12.004","article-title":"Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation","volume":"62","author":"Reischl","year":"2005","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2020.112099_bib32","first-page":"1072","article-title":"Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia","volume":"40","author":"Rasey","year":"1999","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112099_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/31.1.9","article-title":"Nitroimidazole drugs - action and resistance mechanisms I. Mechanisms of action","volume":"31","author":"Edwards","year":"1993","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112099_bib34","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1021\/ja00203a018","article-title":"Kinetics and mechanism of the decomposition in aqueous solutions of 2-(hydroxyamino)imidazoles","volume":"111","author":"Bolton","year":"1989","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112099_bib35","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.3390\/molecules18078618","article-title":"Recent trends in bioorthogonal click-radiolabeling reactions using fluorine-18","volume":"18","author":"Pretze","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112099_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bmcl.2018.01.047","article-title":"Synthesis of novel multivalent fluorescent inhibitors with high affinity to prostate cancer and their biological evaluation","volume":"28","author":"Kwon","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112099_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1021\/acs.bioconjchem.8b00767","article-title":"Synthesis and evaluation of multifunctional fluorescent inhibitors with synergistic interaction of prostate-specific membrane antigen and hypoxia for prostate cancer","volume":"30","author":"Kwon","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2020.112099_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/ml500464f","article-title":"F-18 labeled RGD probes based on bioorthogonal strain-promoted click reaction for PET imaging","volume":"6","author":"Kim","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112099_bib39","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1002\/anie.201510299","article-title":"Mechanical reversibility of strain-promoted azide\u2013alkyne cycloaddition reactions","volume":"55","author":"Jacobs","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112099_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s003350010240","article-title":"Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen\/NAALADase\/folate hydrolase","volume":"12","author":"Bacich","year":"2001","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ejmech.2020.112099_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.21014","article-title":"Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination","volume":"116","author":"Gregor","year":"2005","journal-title":"Int. J. Canc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420300660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420300660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:10:28Z","timestamp":1759327828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420300660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":41,"alternative-id":["S0223523420300660"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112099","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel multifunctional 18F-labelled PET tracer with prostate-specific membrane antigen-targeting and hypoxia-sensitive moieties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112099"}}